Despite its global reach, menstrual health is massively misunderstood. One of the reasons is an apparent lack of knowledge surrounding menstrual health.
Category: Forbes
The Brain Technology Treating Neurological Disorders That Will Benefit From AI
Deep brain stimulation meets machine learning and AI in order to deliver better functional outcomes and quality of life for patients.
InnovationRx: FDA OKs Abbott’s New Pacemaker
InnovationRx is your weekly digest of healthcare news. Sign up!
Prime Therapeutics Hires New CEO To Lead Pharmacy Benefit Combination With MagellanRx
Prime Therapeutics, a pharmacy benefit manager owned by several Blue Cross and Blue Shield health insurers, promoted Mostafa Kama to succeed the retiring Ken Paulus, ,…
New Breakthroughs In Cryopreservation Poised To Transform Organ Transplantation
In 2023, several breakthroughs have shaken the academic community. Freezing entire organs to sub-zero temperatures for future transplantation is now a reality.
There Is No Evidence That Links ADHD Meds To Substance Use Disorder
A new study says taking ADHD medicines like methylphenidate during childhood are not associated with substance use disorders in early adulthood.
A Clear Vision: Anti-VEGF Treatment For Neovascular “Wet” Age-Related Macular Degeneration
This essay delves into the transformative impact of anti-VEGF agents on “wet” age-related macular degeneration.
FDA Gives The Okay For Abbott’s New Minimally Invasive Pacemaker
Medtech giant Abbott announced that its new leadless pacemaker system, Aveir DR, has been approved by the FDA.
The Ozempic Craze Is Sending The Wrong Public Health Message
Ozempic is not FDA approved for the treatment of obesity. Even if it was FDA approved for obesity, wide-scale adoption of the drug is not the solution for obesity.
New Organ Models Open Up Avenues Of Research For Lung Disease
A recent paper brings us closer to creating an accurate model of the lungs. This progress may lead to a deeper understanding of lung diseases and how they can be treated.
